26 Results for "

CCI

" in MedChemExpress (MCE) Product Catalog:
Products (26)

26 Results for "CCI" in MCE Product Catalog:

34
34 Cited Publications
Cat. No.: HY-50910
CAS No.: 162635-04-3
Synonyms: CCI-779
Temsirolimus is an inhibitor of mTOR with an IC50 of 1.76 μM. Temsirolimus activates autophagy and prevents deterioration of cardiac function in animal model .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-N1478
CAS No.: 24512-62-7
Gardenoside is an orally active natural compound found in Gardenia fruits. Gardenoside reliefs chronic constriction injury (CCI)-induced neuropathic pain by regulating the P2X3 and P2X7 receptors. Gardenoside has an inhibitory effect on free fatty acids (FFA)-induced cellular steatosis. Gardenoside reduces reactive oxygen species (ROS). Gardenoside can be used for anti-inflammatory, antinociceptive and hepatoprotective study .
loading...
    loading...
Cat. No.: HY-114410
CAS No.: 292053-42-0
Purity:  99.87%
Research Areas:  

Cancer

CCI-006 is a selective inhibitor and chemosensitizer of MLL-rearranged leukemia cells, by inhibits mitochondrial respiration resulting in insurmountable mitochondrial depolarization and a pro-apoptotic unfolded protein response (UPR) in a subset of MLL-r leukemia cells .
loading...
    loading...
Cat. No.: HY-178281
CAS No.: 931928-13-1
Research Areas:  

Neurological Disease

E0199 is a novel potent dual-target KV7/NaV modulator that activates the KV7 channel (KV7.2/7.3 (EC50 = 12.78 nM), KV7.2 (EC50 = 0.50 μM), and KV7.5 (EC50 = 27.14 nM) channels) while simultaneously blocks the NaV1.7 (IC50 = 0.52 μM), NaV1.8 (IC50 = 0.24 μM), and NaV1.9 (IC50 = 0.16 μM) channels. E0199 shows a potent analgesic effect without affecting heart and skeletal muscle ion channels critically in a chronic constriction injury (CCI) mouse model. E0199 can be used for Neuropathic pain (NP) research .
loading...
    loading...
Cat. No.: HY-106189
CAS No.: 224785-54-0
Target:  

Opioid Receptor

Research Areas:  

Neurological Disease

CCI-1008 is an opioid receptor agonist. CCI-1008 can be used for research on nervous system diseases .
loading...
    loading...
Cat. No.: HY-19888
CAS No.: 1001389-72-5
GSK-1482160 is an orally active and blood-brain barrier penetrant P2X7 receptor (P2X7R) negative allosteric modulator with pIC50s of 8.5 (human) and 6.5 (rat). GSK-1482160 reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity, thereby inhibiting the release of IL-1β. GSK-1482160 is an effective radioligand and can be labeled with radioactive isotopes like 11C or 18F to image P2X7R. GSK-1482160 can be used for the studies of chronic joint pain and chronic constriction injury (CCI) .
loading...
    loading...
Cat. No.: HY-177691
CAS No.: 325780-75-4
CCI17464 is a selective, orally active EP4 partial agonist with a pKi of 7.1. CCI17464 can be used in a Freund's complete adjuvant (FCA) acute rat inflammatory pain model and shows complete reversal of allergic reactions .
loading...
    loading...
Cat. No.: HY-178006
Target:  

P2Y Receptor

Research Areas:  

Neurological Disease

MRS4917 is an orally active, potent selective P2Y14 receptor (hP2Y14R) antagonist (IC50 = 2.88 nM, Ki = 1.67 nM) that shows >18,000 fold selectivity against P2Y6R (IC50 = 54 μM). MRS4917 demonstrates oral efficacy in reversing established mechanoallodynia in the chronic constriction injury (CCI) mouse model, while having no effect on thermoregulation. MRS4917 can be used for neurological diseases research .
loading...
    loading...
Cat. No.: HY-50910R
CAS No.: 162635-04-3
Synonyms: CCI-779 (Standard)
Research Areas:  

Cancer

Temsirolimus (Standard) is the analytical standard of Temsirolimus. This product is intended for research and analytical applications. Temsirolimus is an inhibitor of mTOR with an IC50 of 1.76 μM. Temsirolimus activates autophagy and prevents deterioration of cardiac function in animal model .
loading...
    loading...
Cat. No.: HY-W115558
CAS No.: 17436-02-1
Target:  

Serine Racemase (SR)

Research Areas:  

Neurological Disease

L-Serine-O-sulfate potassium is a serine racemase (Srr) inhibitor. L-Serine-O-sulfate potassium attenuates the chronic constriction injury (CCI)-induced increases in NO levels, nNOS phosphorylation at Ser847, PKC-dependent GluN1 phosphorylation at Ser896, and the development of mechanical allodynia in mice. L-Serine-O-sulfate potassium can be used for the research of peripheral neuropathy .
loading...
    loading...
Cat. No.: HY-122698
CAS No.: 939228-52-1
Purity:  98.45%
Target:  

Apoptosis

Research Areas:  

Cancer

CCI-007 is a small molecule with cytotoxic activity against infant leukemia with MLL rearrangements, with IC50 values of 2.5-6.2 μM in sensitive cells .
loading...
    loading...
Cat. No.: HY-N1478R
CAS No.: 24512-62-7
Gardenoside is an orally active natural compound found in Gardenia fruits. Gardenoside reliefs chronic constriction injury (CCI)-induced neuropathic pain by regulating the P2X3 and P2X7 receptors. Gardenoside has an inhibitory effect on free fatty acids (FFA)-induced cellular steatosis. Gardenoside reduces reactive oxygen species (ROS). Gardenoside can be used for anti-inflammatory, antinociceptive and hepatoprotective study .
loading...
    loading...
Cat. No.: HY-P990248
Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) is an anti-mouse E-Cadherin/CD324 IgG1 monoclonal antibody. Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) can downregulate the HER signaling axis and PI3K/Akt/mTOR signaling pathway. Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) can inhibit the proliferation of tumor cells and induce their apoptosis. Anti-Mouse E-Cadherin/CD324 Antibody (DECMA-1) can be used for researches on cancer and inflammation conditions such as breast cancer, chronic compression injury (CCI) and asthma .
loading...
    loading...
Cat. No.: HY-105818
CAS No.: 80486-69-7
Synonyms: CCI 18773; S-Chlorofluticasone propionate
Target:  

Drug Intermediate

Research Areas:  

Others

Cloticasone propionate (CCI 18773) is an intermediate in the synthesis of Fluticasone propionate (HY-B0154). Fluticasone propionate is a potent topical anti-inflammatory corticosteroid, is a selective glucocorticoid receptor agonist .
loading...
    loading...
Cat. No.: HY-167855
CAS No.: 2801627-78-9
Target:  

P2Y Receptor

Research Areas:  

Inflammation/Immunology

MRS4833 (compound 15) is an orally active, potent, competitive P2Y14R antagonist with an of IC50 of 5.92 nM for hP2Y14R and an IC50 of 4.8 nM for mP2Y14R. MRS4833 reduces airway eosinophilia in a protease-mediated asthma model and reverses chronic neuropathic pain in a mouse CCI model .
loading...
    loading...
Cat. No.: HY-19202
CAS No.: 152362-51-1
Synonyms: rac-EMA401; rac-PD-126055; EMA400
Target:  

Angiotensin Receptor

Research Areas:  

Neurological Disease

rac-Olodanrigan (rac-EMA401; EMA400) is a racemic mixture of the S-enantiomer (EMA401; HY-13106) and R-enantiomer (EMA402). rac-Olodanrigan is a potent and selective AT2 receptor antagonist with IC50s of 75.2 nM and 2918 nM for AT2R and AT1R, respectively. rac-Olodanrigan evokes dose-dependent relief of mechanical allodynia in the ipsilateral hind paws of rats with a chronic constriction injury (CCI) of the sciatic nerve .
loading...
    loading...
Cat. No.: HY-167855S
1’-Epi Gemcitabine hydrochloride- 13C, 15N2 is the 13C- and 15N-labeled MRS4833 (HY-167855). MRS4833 (compound 15) is an orally active, potent, competitive P2Y14R antagonist with an of IC50 of 5.92 nM for hP2Y14R and an IC50 of 4.8 nM for mP2Y14R. MRS4833 reduces airway eosinophilia in a protease-mediated asthma model and reverses chronic neuropathic pain in a mouse CCI model .
loading...
    loading...
Cat. No.: HY-168214
CAS No.: 2315450-35-0
Target:  

Potassium Channel

Research Areas:  

Neurological Disease

Kv7.2/Kv7.3 agonist 1 (Compound 16) is an orally active agonist for KV7.2/7.3 channel (KCNQ2/3) with an EC50 of 1.03 μM. Kv7.2/Kv7.3 agonist 1 exhibits analgesic efficacy in mice chronic constriction injury (CCI) model and mice Streptozotocin (HY-13753)-induced diabetic peripheral neuropathic pain (DPNP) model, with ED50 of 12.02 and 9.63 mg/kg .
loading...
    loading...
Cat. No.: HY-P991310
CAS No.: 1253114-37-2
Synonyms: LT3015; LT-3000

Target:  

LPL Receptor

Research Areas:  

Neurological Disease Cancer

Lpathomab (LT3015; LT-3000) is a human IgG1 monoclonal antibody (mAb) targeting LPA. Lpathomab reduces the release of IL-8 and IL-6 cytokines in SKOV3 cells and blocks LPA-triggered tumor cell migration. Lpathomab reduces neovascularization in Matrigel plug and CNV models. Lpathomab inhibits brain injury in the CCI mouse model. Lpathomab can be used in the study of brain injury, ovarian cancer, diabetic neuropathy, and spinal cord injury. Recommended isotype control: Human IgG1 kappa, Isotype Control (HY-P99001) .
loading...
    loading...
Cat. No.: HY-123382
CAS No.: 1695551-19-9
Target:  

Drug Isomer

GSK-1482160 isomer is the isomer of GSK-1482160 (HY-19888). GSK-1482160 is an orally active and blood-brain barrier penetrant P2X7 receptor (P2X7R) negative allosteric modulator with pIC50s of 8.5 (human) and 6.5 (rat). GSK-1482160 reduces the efficacy of ATP at the P2X7 receptor without affecting its affinity, thereby inhibiting the release of IL-1β. GSK-1482160 is an effective radioligand and can be labeled with radioactive isotopes like 11C or 18F to image P2X7R. GSK-1482160 can be used for the studies of chronic joint pain and chronic constriction injury (CCI).
loading...
    loading...